In this study, we divided the TCGA-PAAD samples into two subtypes based on the differential expression of the invasion-related genes and constructed a prognostic molecular signature consisting of three genes, including LY6D, BCAT1, and ITGB6, based on the DEGs between the two subtypes. This evidence concerns the gene LY6D and pancreatic adenocarcinoma.